XML 34 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
Derivative Financial Instruments
12 Months Ended
Dec. 31, 2023
Derivative Financial Instruments [Abstract]  
Derivative Financial Instruments

Note 8: Derivative Financial Instruments

 

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposures to a wide variety of business and operational risks primarily through management of its core business activities. The Company manages economic risks, including interest rate, liquidity and credit risk, primarily by managing the amount, sources and duration of its assets and liabilities and through the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing and duration of the Company’s known or expected cash payments principally related to certain variable-rate assets.

 

The Company does not use derivatives for trading or speculative purposes. Derivatives not designated as hedges are not speculative and result from a service the Company provides to certain customers. The Company executes interest rate swaps with commercial banking customers to facilitate their respective risk management strategies. Those interest rate swaps are simultaneously hedged by offsetting interest rate swaps that the Company executes with a third party, such that the Company minimizes its net risk exposure resulting from such transactions. As the interest rate swaps associated with this program do not meet the strict hedge accounting requirements, changes in the fair value of both the customer swaps and the offsetting swaps are recognized directly in earnings.

 

Additionally, the Company enters into forward contracts for the future delivery of mortgage loans to third-party investors and enters into IRLCs with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. The forward contracts that are entered into, economically hedge the effect of changes in interest rates resulting from the Company’s commitment to fund the loans. The IRLCs and forward contracts are not designated as accounting hedges and are recorded at fair value with changes in fair value reflected in noninterest income on the consolidated statements of income. The fair value of derivative instruments with a positive fair value are reported in accrued income and other assets in the consolidated balance sheets, while derivative instruments with a negative fair value are reported in accrued expenses and other liabilities in the consolidated balance sheets.

 

The table below presents the notional amount and fair value of the Company’s interest rate swaps, IRLCs and forward contracts utilized at December 31:

 

   2023   2022 
  Notional   Fair   Notional   Fair 
($ in thousands)  Amount   Value   Amount   Value 
Asset Derivatives                
Derivatives not designated as hedging instruments                
Interest rate swaps associated with loans  $68,381   $3,638   $66,477   $5,538 
IRLCs   7,466    45    
-
    
-
 
Forward contracts   
-
    
-
    5,500    26 
Total contracts  $75,847   $3,683   $71,977   $5,564 
                     
Liability Derivatives                    
Derivatives not designated as hedging instruments                    
Interest rate swaps associated with loans  $68,381   $(3,638)  $66,477   $(5,538)
IRLCs   
-
    
-
    3,268    (20)
Forward contracts   10,750    (37)   
-
    
-
 
Total contracts  $79,131   $(3,675)  $69,745   $(5,558)

 

The fair value of interest rate swaps were estimated using a discounted cash flow method that incorporates current market interest rates as of the balance sheet date. Fair values of IRLCs and forward contracts were estimated using changes in mortgage interest rates from the date the Company entered into the IRLC and the balance sheet date.

 

The following table presents the amounts included in the consolidated statements of income for non-hedging derivative financial instruments for the twelve months ended December 31, 2023 and 2022.

 

      Amount of gain (loss) 
($ in thousands)  Statement of income classification  2023   2022 
Interest rate swap contracts  Other income  $132   $19 
IRLCs  Gain on sale of mortgage loans & OMSR   65    (42)
Forward contracts  Gain on sale of mortgage loans & OMSR   (63)   57 

 

The following table shows the offsetting of financial assets and derivative assets at December 31, 2023 and 2022.

 

   Gross
amounts of
   Gross
amounts
offset
in the
   Net amounts
of assets  
presented
in the
   Gross amounts not offset
in the consolidated
balance sheet
     
($ in thousands)  recognized
assets
   consolidated
balance sheet
   consolidated
balance sheet
   Financial
instruments
   Cash collateral
received
   Net
amount
 
December 31, 2023                        
Interest rate swaps  $3,957   $319   $3,638   $
     -
   $2,900   $738 
                               
December 31, 2022                              
Interest rate swaps  $5,540   $2   $5,538   $
-
   $4,480   $1,058 

 

The following table shows the offsetting of financial liabilities and derivative liabilities at December 31, 2023 and 2022.

 

   Gross
amounts of
   Gross
amounts
offset
in the
   Net amounts
of liabilities
presented
in the
   Gross amounts not offset
in the consolidated
balance sheet
     
($ in thousands)  recognized
liabilities
   consolidated
balance sheet
   consolidated
balance sheet
   Financial
instruments
   Cash collateral
pledged
   Net
amount
 
December 31, 2023                        
Interest rate swaps  $3,957   $319   $3,638   $
     -
   $    -   $3,638 
                               
December 31, 2022                              
Interest rate swaps  $5,540   $2   $5,538   $
-
   $
-
   $5,538